Predictmedix AI Inc. (CSE:PMED, OTCQB:PMEDF) told investors it has been invited to showcase its innovative impairment screening technology at the D-30 event in India this weekend.
D-30 is an international gathering of 30 nations recognized by the United Nations for their dedicated efforts in tackling drug addiction on a global scale.
The company noted in a statement that the event represents a significant milestone in the fight against drug addiction and disabilities caused by drug addiction. The primary goal of the program on November 4 is to draw attention to the pressing issue of drug abuse and foster international unity in addressing addiction.
Predictmedix said its technology not only identifies impairment caused by alcohol or drugs such as cannabis but also manages the health of patients entering addiction centers by monitoring their vital parameters in real time and looking at trends for better management/diagnosis as they recover from the underlying drug addiction.
“We are excited to be participating in the D-30 event and we thank the organizers for inviting and showcasing our impairment screening technology in this global forum focusing on combating drug addiction globally,” Predictmedix AI chief operating officer Dr Rahul Kushwah said in a statement.
“Predictmedix AI is committed to leveraging innovation to combat drug addiction and related issues, and this event aligns perfectly with our mission.”
Predictmedix said it has achieved over 90% accuracy in identifying impaired individuals using a combination of multispectral imaging and speech analysis. As the technology is powered by artificial intelligence (AI), its accuracy rate is only expected to increase with time, thanks to the deep learning and machine learning algorithms that allow the system to learn and adapt from new data, it added.
New director of Predictmedix India
The company also announced it has appointed Colonel G Srikumar, an accomplished veteran of the Indian Army, as a new director of Predictmedix India Pvt Ltd.
Colonel Srikumar, who has retired from the army, has joined the company to accelerate business development in key sectors across India.
“His wealth of experience and dedication will contribute significantly to Predictmedix AI's growth and impact in the region,” the company said.
“The utility of Predictmedix AI technology ranges from healthcare, sporting industry, and workplace safety to defense segment and Colonel Srikumar will be assisting the company to accelerate business development in these segments in India along with key international markets in Africa and the Middle East.”
Predictmedix AI also said it will issue 62,250 common shares as consideration for the services provided by a marketing consultant.
Predictmedix AI is an emerging provider of rapid health screening and remote patient care solutions globally. Its Safe Entry Stations - powered by a proprietary artificial intelligence - use multispectral cameras to analyze physiological data patterns and predict a variety of health issues, including 19 physiological vital parameters, impairment by drugs or alcohol, fatigue, or various mental illnesses.
Contact the author at stephen.gunnion@proactiveinvestors.com